Get started
Author

Navidha Aggarwal

Observed name: Aggarwal, Navidha
ORCID: 0000-0002-3696-3189
Observed ORCID: 0000-0002-3696-3189
OpenAlex ID: A5023498409
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025 · Simon I Hay, Kanyin Liane Ong, et al. · The Lancet · 860
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025 · Mohsen Naghavi, Hmwe Hmwe Kyu, et al. · The Lancet · 562
PDF
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
2025 · Austin E Schumacher, Peng Zheng, et al. · The Lancet · 191
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025 · Sarah Brooke Sirota, Rose Grace Bender, et al. · The Lancet Infectious Diseases · 72
Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026 · Damian F Santomauro, Paul Anthony Miller, et al. · The Lancet · 67
PDF
Thiazolidin-2,4-Dione Scaffold: An Insight into Recent Advances as Antimicrobial, Antioxidant, and Hypoglycemic Agents
2022 · Harsh Kumar, Navidha Aggarwal, et al. · Molecules · 57
PDF
Incredible use of plant-derived bioactives as anticancer agents
2025 · Kiran Kangra, Saloni Kakkar, et al. · RSC Advances · 50
PDF
An Understanding of Mechanism-Based Approaches for 1,3,4-Oxadiazole Scaffolds as Cytotoxic Agents and Enzyme Inhibitors
2023 · Davinder Kumar, Navidha Aggarwal, et al. · Pharmaceuticals · 41
Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021
2025 · Tissa Wijeratne, Jiyeon Oh, et al. · Cell Reports Medicine · 30
Emerging synthetic Strategies and Pharmacological Insights of 1,3,4-Thiadiazole Derivatives: A Comprehensive Review
2024 · Davinder Kumar, Navidha Aggarwal, et al. · Future Medicinal Chemistry · 26
Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors
2022 · Meenu Beniwal, Neelam Jain, et al. · BMC Chemistry · 22
PDF
Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives
2023 · Davinder Kumar, Navidha Aggarwal, et al. · Pharmaceuticals · 17
PDF
2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential
2023 · Davinder Kumar, Navidha Aggarwal, et al. · Pharmaceuticals · 15
PDF
Transforming healthcare: the impact of artificial intelligence on diagnostics, pharmaceuticals, and ethical considerations – a comprehensive review
2025 · V.C. Deivayanai, Pavithra Swaminaathanan, et al. · International Journal of Surgery · 13
Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
2025 · Christopher E Troeger, Michael Benjamin Arndt, et al. · The Lancet Child & Adolescent Health · 12
In Silico and In Vitro Screening Constituents of Eclipta alba Leaf Extract to Reveal Antimicrobial Potential
2022 · Rahul Kumar Sharma, Shabana Bibi, et al. · Evidence-based Complementary and Alternative Medicine · 12
PDF
Harnessing 3D printing in bone tissue engineering
2025 · Suchitra Nishal, Parmita Phaugat, et al. · Discover Materials · 10
PDF
An Updated Review on Nanoemulsion: Factory for Food and Drug Delivery
2024 · Virender Kumar, Vandana Garg, et al. · Current Pharmaceutical Biotechnology · 10
Role and Responsibilities of Various Stakeholders in Pharmacovigilance
2024 · Pinki Phougat, Meenu Beniwal, et al. · Current Drug Safety · 8
Skin and Soft Tissue Infections: Current Advancement in Epidemiology, Pathogenesis and Management
2023 · Akriti Goel, Garima, et al. · Journal of Pure and Applied Microbiology · 8
PDF
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026 · Al-Marwani, Sabah, Tran Minh Duc, Nguyen, et al. · University of Birmingham Research Portal (University of Birmingham) · 7
PDF
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026 · Avina Vongpradith, Regina-Mae Villanueva Dominguez, et al. · The Lancet Infectious Diseases · 6
Alopecia Areata: Review of Epidemiology, Pathophysiology, Current Treatments and Nanoparticulate Delivery System
2024 · Robel Singh, Pawan Kumar, et al. · Therapeutic Delivery · 6
Natural Antimicrobial Monoterpenes as Potential Therapeutic Agents in Vaginal Infections: A Review
2024 · Preeti Singh, Satish Sardana, et al. · Journal of Pure and Applied Microbiology · 5
Recent advances, challenges and updates on the development of therapeutics for malaria
2023 · Nandal, Rimmy, Kumar, Davinder, et al. · EXCLI journal · 5
PDF
Works count: 52
Citation count: 2,129
H-index: 13
I10-index: 18
Year
Topic
Type